# Dexmedetomidine and Propofol for Pediatric MRI Sedation

> **NCT03513757** · PHASE4 · COMPLETED · sponsor: **Medical College of Wisconsin** · enrollment: 40 (actual)

## Conditions studied

- Headache
- Tumor
- Seizure Disorder
- Neurofibromatoses
- Hydrocephalus
- Abdominal Neoplasm
- Spine Deformity

## Interventions

- **DRUG:** propofol
- **DRUG:** Dexmedetomidine
- **DRUG:** Glycopyrrolate
- **DRUG:** Lidocaine 1% Injectable Solution
- **DRUG:** Nitrous Oxide
- **DRUG:** Sevoflurane

## Key facts

- **NCT ID:** NCT03513757
- **Lead sponsor:** Medical College of Wisconsin
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-04
- **Primary completion:** 2018-08-21
- **Final completion:** 2018-10-21
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2020-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03513757

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03513757, "Dexmedetomidine and Propofol for Pediatric MRI Sedation". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT03513757. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*